Gaspar Leonor M, Gonçalves Catarina I, Nobre Ema L, Fonseca Fernando, Amaral Cláudia, Duarte João S, Raimundo Luísa, Saraiva Catarina, Cortez Luísa, Marques Olinda, Lemos Manuel C
CICS-UBI, Health Sciences Research Centre, University of Beira Interior, 6200-506 Covilhã, Portugal.
Serviço de Endocrinologia, Diabetes e Metabolismo, Hospital de Santa Maria, Unidade Local de Saúde Santa Maria, 1649-028 Lisboa, Portugal.
J Clin Transl Endocrinol. 2025 Apr 4;40:100389. doi: 10.1016/j.jcte.2025.100389. eCollection 2025 Jun.
Mutations in several genes have been associated with familial forms of pituitary adenomas. Sporadic pituitary adenomas (i.e. with no family history or coexistent endocrine tumours) are also occasionally found to result from germline mutations in these genes, especially in young patients with larger tumours. The aim of this study was to determine the frequency of germline mutations in patients with young-onset sporadic pituitary macroadenomas. A cohort of 225 Portuguese patients with sporadic pituitary macroadenomas diagnosed before the age of 40 years was studied by whole exome sequencing (WES) followed by the analysis of a virtual panel of 29 genes that have been associated with predisposition to pituitary adenomas. Pathogenic and likely pathogenic variants were identified in 16 (7.1 %) of patients. The affected genes were (n = 4), (n = 4), (n = 2), (n = 2), (n = 1), (n = 1), (n = 1), and (n = 1). In patients diagnosed under the ages of 30 and 18 years, the frequency of pathogenic and likely pathogenic variants increased to 9.0 % and 12.0 %, respectively. This is so far the largest multigene analysis of patients with young-onset sporadic pituitary macroadenomas. We confirmed the as the most frequently involved gene, but also uncovered rarer genetic causes of pituitary adenomas. The results may contribute to a better understanding of the genetic landscape of these tumours and help to decide which genes to include in the genetic screening of patients with young-onset pituitary macroadenomas.
多个基因的突变与垂体腺瘤的家族性形式相关。散发性垂体腺瘤(即无家族病史或并存内分泌肿瘤)偶尔也被发现是由这些基因的种系突变引起的,尤其是在肿瘤较大的年轻患者中。本研究的目的是确定年轻发病的散发性垂体大腺瘤患者中种系突变的频率。通过全外显子组测序(WES),然后分析与垂体腺瘤易感性相关的29个基因的虚拟面板,对225例40岁前诊断为散发性垂体大腺瘤的葡萄牙患者进行了研究。在16例(7.1%)患者中鉴定出致病性和可能致病性变异。受影响的基因有(n = 4)、(n = 4)、(n = 2)、(n = 2)、(n = 1)、(n = 1)、(n = 1)和(n = 1)。在30岁及18岁以下诊断的患者中,致病性和可能致病性变异的频率分别增至9.0%和12.0%。这是迄今为止对年轻发病的散发性垂体大腺瘤患者进行的最大规模多基因分析。我们证实了 是最常受累的基因,但也发现了垂体腺瘤更罕见的遗传原因。这些结果可能有助于更好地了解这些肿瘤的遗传格局,并有助于决定在年轻发病的垂体大腺瘤患者的基因筛查中纳入哪些基因。